Healthcare -
Biotechnology - NASDAQ - GB
$ 11.311
-0.519 %
$ 8.23 B
Market Cap
2.04
P/E
Price Target
Average
47.53%
Revenue Forecast
Estimate
88.39%
EBIT
Estimate
--5.15%
Net Income
Estimate
--55.97%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Roivant Sciences Ltd.
Wall Street analysts predict an average 1-year price target for ROIV of $16.7 , with forecasts ranging from
a
low of
$12.5 to a high of $20 .
ROIV Lowest Price Target
Wall Street Target
12.5 USD
10.51%
ROIV Average Price Target
Wall Street Target
16.7 USD
47.53%
ROIV Highest Price Target
Wall Street Target
20 USD
76.82%
REVENUE FORECAST
Revenue Forecast Chart ROIV
EBIT FORECAST
EBIT Forecast Chart ROIV
NET INCOME FORECAST
Net Income Chart ROIV